Pharmanutra SpA
MIL:PHN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
P
|
Polaris Media ASA
F:93J
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHN's stock price target?
Price Target
94.86
EUR
According to Wall Street analysts, the average 1-year price target for PHN is 94.86 EUR with a low forecast of 92.92 EUR and a high forecast of 102.9 EUR.
What is the Revenue forecast for Pharmanutra SpA?
Projected CAGR
9%
Over the last 9 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Pharmanutra SpA?
Projected CAGR
16%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Pharmanutra SpA?
Projected CAGR
9%
Over the last 9 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 8 years is 9%.
What is the Pre-Tax Income forecast for Pharmanutra SpA?
Projected CAGR
20%
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Pharmanutra SpA?
Projected CAGR
22%
Over the last 9 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 22%.